Back
Air Liquide SA Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
46
AIQUY
Air Liquide SA
Last Price:
$41.92
Seasonality Move:
2.38%
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
$64.05
Seasonality Move:
14.49%
Sell
46
Air Liquide SA (AIQUY)
is a Sell
Is Air Liquide SA a Buy, Sell or Hold?
-
The current Air Liquide SA [AIQUY] share price is $41.92. The Score for AIQUY is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
AIQUY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $64.01. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AIQUY Stock Price Chart
What is Air Liquide SA's stock price today?
-
The Air Liquide SA share price today is $41.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AIQUY is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $64.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
AIQUY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 70.23 | Buy |
| Chaikin Money Flow: | -30126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.4 - 40.64) | Buy |
| Bollinger Bands (100): | (33.25 - 38.91) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.59 | Buy |
| Relative Strength Index (14 RSI): | 61.82 | Buy |
| Chaikin Money Flow: | -423346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.72 - 63.96) | Buy |
| Bollinger Bands (100): | (52.92 - 60.34) | Buy |
AIQUY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.77 | Buy |
| 20-day SMA: | 39.21 | Buy |
| 50-day SMA: | 38.55 | Buy |
| 200-day SMA: | 36.13 | Buy |
| 8-day EMA: | 40.78 | Buy |
| 20-day EMA: | 39.8 | Buy |
| 50-day EMA: | 38.45 | Buy |
| 200-day EMA: | 36.34 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.65 | Buy |
| 20-day SMA: | 60.57 | Buy |
| 50-day SMA: | 55.98 | Buy |
| 200-day SMA: | 53.96 | Buy |
| 8-day EMA: | 63.48 | Buy |
| 20-day EMA: | 60.94 | Buy |
| 50-day EMA: | 58.06 | Buy |
| 200-day EMA: | 53.2 | Buy |
Air Liquide SA Earnings Growth & AIQUY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.25 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Air Liquide SA Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||